Unichem Laboratories gets 5 USFDA observations at Goa

Unichem Laboratories got five USFDA observations at its Goa plant. Key levels: support near ₹482, resistance at ₹600, 52-week high at ₹687. Unichem Laboratories Limited [

] is likely to remain in focus today after the US Food and Drug Administration (USFDA) completed an inspection of the company’s Goa formulation facility at Pilerne between September 21 and 26, 2026. The inspection concluded with five observations, primarily related to procedural enhancements. Why it matters: the Goa plant, built in 1997, serves export markets, so USFDA outcomes are tracked. The final outcome will depend on the company's response and the regulator's assessment. The stock closed at ₹549.70 on September 25, down 0.53%. It is up about 25% in calendar 2026 so far. The market cap is ₹3,874 crore, and the P/E is 12.71 against a sector P/E of 30.84. Technically, the price has been moving between ₹482 and ₹600 since August. Support is near ₹482, immediate resistance is at ₹600, and the 52-week high of ₹687 is the major resistance above it. Volume has been low in this range. My view is neutral. Price is still inside its range. I will watch for a close above ₹600 or below ₹482 with volume. I do not hold this stock. Disclaimer: I, Akhilesh Jat (SEBI RA Reg. No. INH000016649), do not hold any position in the stock discussed. This content is informational, not a recommendation. Investments in securities are subject to market risks. Read all related documents carefully before investing.